Investment
Features
FeesSafety
Academy
More
Pluang+

Ondas completes five acquisitions, expects 76% Q3 revenue growth and $1B run rate by 2026

Market News
28 Sep 2026
Seeking Alpha
View Source
Bullish
Ondas completes five acquisitions, expects 76% Q3 revenue growth and $1B run rate by 2026

Ondas completed five acquisitions in September, investing $261 million in companies focused on precision strike and counter-drone technologies. The company projects a 76% sequential revenue increase for Q3 and aims to reach a $1 billion annualized revenue run rate by the end of 2026, with adjusted EBITDA profitability targeted for Q4 2027. Ondas' $757 million backlog, combined with favorable U.S. policy and NATO demand, supports its growth outlook in the defense sector. However, risks remain from dilution, integration challenges, and short interest.

Ondas and its recent activities provide context for the Industrials sector's performance on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Sep 29, 2026 03:41 WIB: out of 93 priced US Industrials stocks, 25 rose and 67 fell. Notable movers include Bloom Energy at USD 265.00 with a -8.21% change, Archer Aviation Inc at USD 5.23 down 6.77%, and Boeing Co at USD 185.03 down 6.58%, with Boeing showing 100% buy order activity and a typical hold time of 83 days.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
2 hours ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
2 hours ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
3 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
3 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App